Inflammatory infiltration and inappropriate friction remain the two main challenges in treating osteoarthritis (OA). An effective treatment platform is anticipated to lubricate the cartilage and ameliorate intra-articular inflammation. Herein, injectable hydrogel microspheres with chondroitin sulfate (Chs)/sericin methacryloyl (SerMA) designed as the core and grafted with folic acid (FA)- and 78c-modified liposomes (78c@Lipo-FA) by DSPE-PEG2k-GPLGLAGQC (DPG) peptides, namely LFDCS, was formed by thin-film hydration and microfluidic methods. Physically, LFDCS exhibited cartilage lubrication and adhesion capability as the bionic bearings. Meanwhile, with the degradation of LFDCS, Chs were set out to promote chondrocyte function. Physiologically, 78c@Lipo-FA were released from LFDCS enzymatically responsible to matrix metalloprotein-9 (MMP9) due to the split of DPG motif, which specifically bound to classical-activated macrophages (M1) by ligating to FA receptor through FA and inhibit M1 function by 78c, consequently rescued cartilage from degradation by inflammation. Mechanically, an RNA sequencing analysis revealed that the LFDCS could ameliorate chondrocyte dysfunction by down-regulating PI3K/AKT signaling and inflammation response. LFDCS greatly reduced friction on articular surfaces, suppressed M1-induced inflammation and attenuated chondrocyte dysfunction in OA rats. In conclusion, the bionic bearing-inspired lubricating microspheres characterized by M1-phenotype macrophage-targeted addresses the unfavorable factors of both the physical and physiological microenvironments in macrophage-mediated diseases. Graphic abstract
Background: Intervertebral disc degeneration (IVDD) is a leading cause of low back pain, yet current therapies fail to reverse the degenerative process or restore disc function. Ferroptosis, a form of iron-dependent cell death characterized by lipid peroxidation, has been implicated in IVDD progression.
Osteoporosis (OP) is a systemic skeletal disease characterized by reduced bone mass and a degenerative bone microarchitecture. Apigenin (API), a flavonoid derived mainly from celery, has been reported to be beneficial for the treatment of OP; however, the underlying mechanisms remain unclear. Moreover, the effects of API on bone-forming cells, including mesenchymal stem cells and osteoblasts, remain unclear. In the present study, we first determined that API treatment could promote bone formation, improve bone metabolism in ovariectomized (OVX) mice, and effectively ameliorate bone loss, as supported by micro-CT scanning and histological staining of mouse femurs. In vitro investigations have confirmed that API has a bidirectional regulatory effect on bone metabolism, promoteing osteogenic differentiation and inhibiting osteoclastogenesis. The further study displayed that the promotion of osteogenesis of bone marrow-derived mesenchymal stem cells from OVX mice mainly through regulating SIRT1 and its downstream HIF1α signaling. In summary, API treatment may be a novel and promising therapeutic strategy for the treatment of OP.
6 October 2025 in Journal of Cellular and Molecular Medicine
Total joint arthroplasty (TJA) is an effective intervention for end‐stage arthritis; however, its long‐term success is often compromised by wear particle–induced osteolysis, leading to aseptic loosening and implant failure. This study investigates the potential of kaempferol (Ka), a natural flavonoid with anti‐inflammatory properties, to alleviate osteolysis by modulating NLRP3 inflammasome activation. In a murine calvarial osteolysis model, Ka administration significantly attenuated bone loss induced by CoCrMo alloy particles. Mechanistically, Ka dose‐dependently inhibited NLRP3 inflammasome activation in macrophages, as evidenced by reduced IL‐1β secretion, decreased ASC oligomerisation and suppressed GSDMD cleavage, ultimately leading to decreased pyroptosis. These effects were found to be partially mediated via GPR109a. Furthermore, Ka markedly suppressed osteoclast differentiation and activity both in vivo and in vitro while promoting osteoblast differentiation, thereby contributing to the restoration of bone remodelling balance. Taken together, our findings suggest that Ka exerts a protective effect against wear particle–induced osteolysis by targeting the NLRP3 inflammasome and modulating osteoimmune responses, which may offer a novel therapeutic strategy to manage periprosthetic osteolysis and prolong implant longevity.
The global rise of multidrug resistance (MDR) across bacterial pathogens poses a severe threat to public health, with the food chain serving as a critical reservoir and transmission route for resistant clones. This study investigated the genomic epidemiology of Staphylococcus aureus in retail pork from Beijing, China, and Copenhagen, Denmark, with a focus on MDR patterns and associated genetic elements. Among 134 isolates, the livestock-associated clonal complex CC398 was the dominant lineage (24.63%) and exhibited a high burden of MDR (48.48%), carrying resistance genes to β-lactams (blaZ and mecA), tetracyclines (tetM and tetK), and aminoglycosides. Notably, MRSA isolates displayed a significantly higher MDR prevalence (73.53%) compared to MSSA isolates (18.00%), underscoring methicillin resistance as a key marker for broader resistance phenotypes. Phylogenetic analysis revealed the segregation of CC398 into distinct sub-lineages, with the livestock-associated branch consistently linked to a characteristic tetracycline–β-lactam MDR profile. Furthermore, high frequencies of mobile genetic elements, such as the rep16 plasmid, were associated with MDR dissemination in CC398. These findings highlight retail meat as an important reservoir for MDR S. aureus and illustrate how livestock-adapted clones contribute to the environmental burden of antimicrobial resistance. This study underscores the need for integrated One Health surveillance that connects veterinary, food safety, and human health sectors to monitor and contain the spread of MDR bacteria across ecological niches.
Background: Thoracolumbar fascia injury (FI) which has been demonstrated to be related to residual pain after kyphoplasty has received increasing attention. However, there is currently no definite treatment for FI in osteoporotic vertebral fracture (OVF) patients. This study aimed to evaluate the efficacy of percutaneous kyphoplasty (PKP) combined with local injection therapy for the treatment of OVF patients with FI. Methods: Seventy‐one OVF patients with FI were included in this study and were divided into two groups (Group 1, kyphoplasty without local injection therapy; Group 2, with local injection therapy). The demographics of patients between the two groups were compared. Then the clinical efficacy was compared between the two groups preoperatively and at different follow‐up time points. The patients in Group 2 were further classified into two groups based on the severity of FI and the clinical efficacy was evaluated between these two groups. Results: The operative time was significantly longer in Group 2 than in Group 1. In Group 2, the visual analogue scale (VAS) and Oswestry disability index (ODI) scores were significantly lower one day and 1 month postoperatively compared to the values in Group 1. The satisfaction survey also presented that more patients were satisfied with the surgery one day postoperatively in Group 2. Further comparison between the patients with severe or nonsevere FI showed that there were no statistically significant differences in VAS and ODI scores at each follow‐up time point. Conclusions: Local injection therapy combined with PKP is a safe and effective strategy for improving early postoperative recovery and reducing early residual pain in OVF patients with FI.